Brian Vastag's Concise Review of How Drug Companies Use CME for Marketing
What follows is an article written about commercial CME by the science journalist Brian Vastag, who writes for a number of publications, including the Washington Post, U.S. News and World Report, and JAMA. You can read the article on his blog at http://brianvastag.net/2009/10/cme/, but I have also reproduced in its entirety below, because I feel it is such an important piece of journalism. Congrats to Brian Vastag for telling it like it is. A scientific journal recently commissioned this story from me, but after I reported and wrote it, the journal killed it. I think it’s an importa

Tom Sullivan, of ACRE Fame, Is Swimming in Drug Company Cash
Wherever there is a vocal battalion of defenders of drug industry funded medical education, you are certain to find Tom Sullivan leading the charge. Sullivan writes the most prolifi

New York Times Covers Industry Funding of CME
It is unusual for the New York Times, or any other national news organization for that matter, to focus industry-funded CME. With examples of corrupted business practice everywhere, this particular little slice of corruption is easily glossed over. But Duff Wilson, in toda

Indianapolis Star Reports on CVS Caremark-Eli Lilly Marketing Scam
For most of us, blogging is a labor of love, and our payment is the possibility of having a positive impact in the world. So it was gratifying to see that the Indianapolis Star published this

CME Outfitters: Guilty of Pro-Seroquel Bias, According to ACCME
In ACCME's testimony before the Senate Special Committee on Aging on July 29 of this year, Dr. Murray Kopelow, the chief executive of ACCME, defended the integrity of the embattled organization in par